Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02164825
Other study ID # CHTSA001
Secondary ID
Status Completed
Phase N/A
First received June 5, 2014
Last updated February 4, 2015
Start date January 2014
Est. completion date August 2014

Study information

Verified date June 2014
Source Centro Hospitalar do Tâmega e Sousa
Contact n/a
Is FDA regulated No
Health authority Portugal: Ethics Committee for Clinical Researc
Study type Interventional

Clinical Trial Summary

Single-shot femoral nerve block is similar to continuous epidural technique for postoperative analgesia in total knee arthroplasty


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Elective total knee arthroplasty

Exclusion Criteria:

- Coagulopathy

- Neuropathy

- Morbid obesity

- local anesthetics allergy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Drug:
Ropivacaine perineural injection
Ultrasound guided single-shot femoral nerve block
morphine and ropivacaine
Continuous epidural analgesic perfusion Epidural perfusion with morphine and ropivacaine.

Locations

Country Name City State
Portugal Centro Hospitalar Tâmega e Sousa Penafiel

Sponsors (1)

Lead Sponsor Collaborator
Centro Hospitalar do Tâmega e Sousa

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Score on the numeric pain score Patients will be evaluated at 48 hours. At these time frame pain score at rest and during movement will be accessed. 48 hours No
Secondary Side effects as a measure of safety and tolerability Side effects of both interventions. Number of patients with side effects like nausea, vomiting, hypotension and pruritus. 48 hours Yes
Secondary Rescue analgesic consumption. Opioid rescue needs in the first 48 hours after surgery. 48 hours No
Secondary Patients satisfaction. Evaluation of patient´s satisfaction with pain control (asking the patient to classify the grade of satisfaction). 48 hours No